Orchestra BioMed™ Appoints Drug-Device Combination Expert Jagdish Parasrampuria as Vice President of Pharmaceutical Development

NEXT STORY
ASLAN Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
PREV STORY
Worldwide Disposable Syringes Industry to 2026 – Key Drivers, Restraints and Opportunities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Atara Biotherapeutics to Participate in the 37th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), ...

author_avatar
NASDAQ Market News

Delcath Announces Exit from Convertible Note

NEW YORK, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional ...

author_avatar
NASDAQ Market News

Hemispherx to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

ORLANDO, Fla., Aug. 24, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) ...

author_avatar
NASDAQ Market News